Vero Cell-based Vaccine Production: Rabies and Influenza Cell lines, Media and Bioreactor Options
26 Feb 2014The Vero cell line is one of the most satisfactory based on its stability and well-documented performance in quality and quantity of viral yield. It has received FDA approval and is used throughout the world. This white paper reviews strategies for optimizing vaccine production with examples given for rabies and influenza using cell culture systems.
Related Products
Request Quote for All Products
Eppendorf New Brunswick™ BioFlo®/CelliGen® 510
EppendorfBioFlo 510 Fermentors and CelliGen 510 Bioreactors are intermediate systems ideal for pilot to small scale production processes. The modular design features a wide variety of standard options allowing this system to be flexible enough to meet most process requirements. Eppendorf New Brunswick™ BioFlo®/CelliGen® 510 Working volumes: 10.75 L to 32.0 L Applications: Laboratory and pilot scale fermentation of aerobic and anaerobic bacteria, yeasts, and fungi; Laboratory and pilot scale cell culture of mammalian, insect, and human cell lines; Special applications such as stem cell culture, vaccine, monoclonal antibody, or biofuel/biopolymer production; Suitable for batch, fed batch, and continuous processes